Drug disposition & Fate of drugs Flashcards

1
Q

MUST have some ability to dissolve in WATER to move around (be
absorbed, reach sites of action.)

A

Drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

must also have a
certain degree of lipid solubility to move around (leave and enter capillaries,
enter and leave cells.)

A

Drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Drug concentrations in the ____ (measured in either serum or plasma)
are USUALLY proportional (and usually linear) to drug concentrations at the
site of action.

A

blood stream

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Drug concentration in the _______ is ALMOST ALWAYS an excellent
predictor of drug action (either efficacy or toxicity)

A

blood stream

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

are the consequence of physiologic process (that may or
may not be altered by disease.)

A

Pharmacokinetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

are the PRIMARY difference between basic and clinical
pharmacology.

A

Disease-included differences

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

are the PRIMARY difference between
Veterinary pharmacology and Human pharmacology”.

A

Species differences in pharmacokinetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

General Principles of Routes of Administration (Drug Absorption)

A

Drug dissolve in body fluid (water).
Drugs enter the circulatory system as fluid enters the circulatory system.
Drugs must enter the circulatory system before they can distributed to sites of
action.
(Drugs for enteric effects are an obvious exception.)
Therefore, drugs are not IN the body until they are IN the bloodstream.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Advantages of Oral administration

A

Convenient, cheap, no need for sterilization, variety of dose forms
(fast release tablets, capsules, enteric coated layered tablets, slow release,
suspensions, mixtures)
You can get the dose back of you move fast enough.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Disadvantages of Oral administration

A

Variability due to physiology, feeding, disease, etc.
Intractable patients
First-pass effect
Efficiently metabolized drugs eliminated by the liver before they reach the
systematic circulation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Patient and Pharmaceutical Factors

A

Pill compression, coatings, suspending agents, etc.
GI transit time (too slow or too fast), inflammation, malabsorption, syndromes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Regional Differences of Oral administration

A

Stomach
mechanical preparation
“flat” absorptive surface
pH extreme
Rumenoreticulum
stratified squamous epithelium
pH varies with diet
metabolism by bacterial flora
significant volume of fluid compared to body water
Small Intestine
large absorptive functions
relatively neutral pH
Colon/Rectum
accessible
large absorptive surface

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

The bolus remains relatively spherical.

A

Liqid soluble vehicle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

entry of drug into
circulatory system limited by rate of drug ______ (Movement from the
“bolus” to the tissue fluid).

A

“dissolution”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Advantages of Subcutaneous Administration

A

Can be given by the owner (small patients)
Vasoconstrictor can be added to prolong effect at site of interest

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Disadvantages of Subcutaneous Administration

A

Variability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Much like intramuscular (though the architecture of the tissue is much different)

A

process of subcutaneous

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Patient and Pharmaceutical Factors of Subcutaneous

A

More autonomic control over blood flow (than muscle)
dehydration, heat, cold, stress

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Topical Advantages

A

IF systemic therapy – easy painless application (e.g. mass medication of cattle)
IF skin therapy – reduced systemic effects/enhanced skin effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Topical Disadvantages

A

Patients groom themselves (topically applied, orally absorbed)
Toxic skin reactions
Variable blood flow to skin
COMPLEX relationship between drug, vehicle , skin physiology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

process of topical

A

Diffusion through stratified epithelium
“Passage” through adnexal structures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Patient and Pharmaceutical Factors of Topical

A

Lipid solubility and molecule size
Skin hydration and abrasion
Area of application
Ambient an patient temperature

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Vehicle Effects of Topical

A

“like” vehicles retain drug on skin surface
(e.g, aqueous drug in aqueous vehicle, lipid drug in lipid vehicle)
Drugs in “unlike” vehicles leave the vehicle to move on to skin
(e.g, aqueous drug in lipid suspension, lipid drug in aqueous suspension)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Intraperitoneal Advantages

A

Larger absorptive surface are than IM / Subcutaneous

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Intraperitoneal Disadvantages

A

Drugs or vehicles may cause peritonitis
Damage to organs by needles
Injection into organs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Patient and Pharmaceutical Factors of Intraperitoneal

A

Generally restricted to laboratory animals.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Intrathecal Advantages

A

Direct delivery to site of action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Disadvantages Intrathecal

A

Difficult dose calculation
Intrathecal
CSF volume is not proportional to body weight
Toxicity likely, and toxicity may be unusual
Introduce infection into a VERY bad location

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Process Intrathecal

A

Absorption is usually by diffusion and very slow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Intra-actular Advantages

A

Direct delivery to site of action. High concentrations can be produces in the
joint.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Disadvantages Intra-actular

A

It may be difficult to hit the joint space depending on the species (size of joint
space).
Difficult dose calculation
Joint space volume depends on disease
Introduce infection. (PSGAG - Adequan® - interjections now generally get
“antimicrobial chaser”)
Joint “flushes: don’t count.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Process Intra-actular

A

Absorption from the site to systemic is variable but often quite fast. Systemic
concentrations of the drug may be produced. Effects in joint may not persist.
(Drug and dose form dependent)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Used primarily for anti-tumor therapy and infectious
disease therapy when blood supply is questionable.

A

Intra-arterial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Produce extremely high concentrations “pointed at” (this is not really targeting)
the tissue of interest.

A

Intra-arterial (advantage)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Disadvantages Intra-arterial

A

Dose calculation is best guess.
Intra-arterial lines difficult to insert/maintain.
Dosing is still really systemic.
Limited number of efficacy studies (especially in animals)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Process of Intra-arterial

A

Produce AND SUSTAIN high blood-to-tissue gradient to increase tissue
concentrations of drug. Requires sustained infusion or application of tourniquet
following bolus dosing.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Per rectum advantages

A

Access to GI absorption in unconscious or vomiting patients
Drug can be recovered before absorption is complete

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Per rectum disadvantages

A

Animals may not willingly retain the drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Process Per rectum

A

As for oral without mechanical preparation by stomach

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Drug Distribution Physiologic “spaces”

A

Vascular space (plasma / plasma water + RBC’s)
There is also “tissue space”
Size -7% of body weight
Equilibria
between water and various plasma / serum proteins
between ionized and unionized drug
between ionized and unionized drug
between plasma and cells
Distribution in 10 to 30 minutes (mixing)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Extracellular Space (exist in both vascular and tissue spaces)

A

Size
15 – 20% of body weight
includes extracellular fluid in bloodstream (plasma)
Equilibria
between water and proteins
between ionized and unionized drug
Distribution in 30 minutes to 1.5 hours

41
Q

Intracellular space (exist in both vascular and tissue spaces)

A

Size
35 – 45% of body weight
Equilibria
between ionized and unionized drug
intracellular pH different (lower) than extracellular
Distribution in 30 minutes to 12+hours

42
Q

Reserved spaces

A

Special barriers between plasma and tissue fluid CSF
aqueous humor
prostatic fluid
Distribution in minutes to never

43
Q

Movement between spaces

A

Vascular space (extracellular) to tissue (extracellular) space
Transcytotic
Endothelial junctions wit inflammation
Diffusion through endothelial cell membranes
Carried in cells or on proteins in very special circumstances
Extracellular space (of tissue) to intracellular space (of tissue)
Diffusion through lipid bilayer of cells
Vascular extracellular space to vascular intracellular space (drugs can mocve
into RBC’s and WBC’s)
Diffusion through lipid bilayer of cells
WBC may actively acquire certain drugs

44
Q

Diffusion Limited Distribution

A

Diffusion is usually slow (relative to mixing and distribution within vascular
system)
Tissue distribution of the drug controlled by the ability of the drug to diffuse into
the tissue

45
Q

Blood flow limited distribution

A

Diffusion can be VERY rapid
Tissue distribution of the drug controlled by the rate of drug delivery to the tissue
(total mg/minute) which is controlled by blood flow / gram of tissue
Brain and liver concentration rise faster than muscle or fat

46
Q

_____________ concentration rise faster than muscle or fat

A

Brain and liver

47
Q

How does Enterohepatic Circulation work?

A

Drug or it’s Phase II conjugate excreted in bile
Drug reabsorbed or Conjugate cleaved by bacteria and drug reabsorbed

48
Q

Why do you care? (Enterohepatic Circulation)

A

interrupt to improve drug elimination
Insecticide poisonings, Phenobarbital overdoses, et

49
Q

How does Mammary Excretion work?

A

Non – ionic Diffusion (lipid solubility and size dependence)
Inflammation reduces barriers to penetration (masititis)
Ion trapping
normal milk pH = 6.6 (slightly acidic versus blood)
Mastitic milk pH is slightly higher

50
Q

Why do you care? (Mammary Excretion)

A

May affect treatment of some bacterial infections of the mammary gland
Nursing animals may be exposed to toxic concentrations of drug in the milk

51
Q

The volume of fluid that “appears” to contain the amount of drug in the
body

A

Volume of Distribution

52
Q

Partially determines the relationship between dose and plasma concentration

A

Volume of Distribution

53
Q

Roughly describes “tissue penetration”

A

Volume of Distribution

54
Q

Units

A

Liters or milliliters describing the whole animal
Liters/kg or milliliters/kg

55
Q

Defines the volume of fluid that must be processed by organs of elimination

A

Volume of Distribution

56
Q

is usually slow (relative to mixing and distribution within vascular
system)

A

Diffusion

57
Q

How does Salivary Excretion work?

A

Non – ionic diffusion into salivary secretions
Drug in saliva passes into GI tract

58
Q

They can recycle certain drugs like enteroheptic circulation (prolonged elimination)

Can also trap certain drugs in the rumen pH dependent (enhanced elimination)

A

Ruminants

59
Q

Conversion of a drug entity to a metabolite

A

Biotransformation

60
Q

Chemical Mechanisms of Biotransformation

A

Oxidation, hydroxylation, hydrolysis, reduction, conjugation, (acetylation,
glucuronidation, sulfation, etc.)

61
Q

Efficiency (rate) of Biotransformation

A

Metabolic activity for a specific drug
Blood flow to the organ
Health of the organ and health of the circulatory system

62
Q

organs involved in biotransformation

A

Liver (most important for most drugs)
Lungs (especially for autocoids)
Kidneys

63
Q

Types of Biliary Excretion

A

Active secretion
Passive secretion

64
Q

Drugs with molecular weights > 300
mostly conjugates of original drug

A

Active secretion

65
Q

Drugs with molecular weights < 300
biliary concentrations similar to plasma water

A

Passive secretion

66
Q

Process of Renal Elimination

A

(Glomerular filtration + tubular secretion) – passive reabsorption = renal
elimination

67
Q

passive elimination of drug dissolved in plasma water

ionized and unionized

NOT protein bound drug

A

Glomerular filtration

68
Q

energy dependent excretion by proximal kidney tubule

organic acid and organic base pumps

includes protein bound drugs

A

Tubular secretion

69
Q

Passive reabsorption can be reduced by_____ or by ______

A

disease (accidental)
therapy (intentional)

70
Q

The volume of plasma water cleared of the drug during a specified time period.

A

Clearance

71
Q

Organ clearance is calculated by determining the ___

A

flow (Q) and the efficiency of
extraction

C𝑙𝑒𝑎𝑟𝑎𝑛𝑐𝑒 = 𝑄 𝑥 𝐸

72
Q

is the sum of all organ clearances

A

Total body clearance (Clt)

73
Q

Units of Clearance

A

Volume / unit time (1/hr, 1/min, ml/hr etc) describing whole animal

Volume / kilogram / unit time (1/kg/hr, ml/kg/min etc.)

74
Q

The time for elimination of one half of the total amount in the body.

A

Elimination Half – Life or Half life

75
Q

longest half – life

A

gentamicin example

76
Q

is an initial dose of drug given to shorten the time to reach the
steady-state concentrations.

A

loading dose

77
Q

describes the rate of drug movement (oral,
IM, SC, etc.) from the dose to the circulatory system.

A

Absorption Rate Constant

78
Q

is a common measure used to
compare two different drug formulations (tablets vs. elixir) or to compare
products sold by two different manufacturers (trade name drugs vs. generics).

A

Bioavailability

79
Q

The fraction of the dose absorbed determines a drug’s ____

A

bioavailability

80
Q

Attempt to describe the actual events which control drug absorption,
distribution, and elimination

A

Physiologic models

81
Q

Attempt to accurately predict the time course of drug concentrations in one
(usually blood or plasma) or two (urine as well) body fluids. Predictions area
generally made for tissues which can be sampled from intact patients.

A

Mathematic Models

82
Q

Enumerate Body Compartments

A

Central Compartment
Blood volume
Organs of elimination
Peripheral compartment
Muscle
Subcutis
Lung Tissue
Deep compartments
Fat (poor blood supply, lipid soluble drugs)
Kidneys (amino glycosides)

83
Q

If the pharmacokinetics of ABSORPTION change when we increase the dose , the drug is said to exhibit -_____

A

dose – dependent
absorption

84
Q

If the pharmacokinetics of ELIMINATION change when we increase the dose ), the drug is said to exhibit____

A

dose – dependent elimination.

85
Q

The sum of all individual organ
clearances. Usually determined by
plasma sampling

A

Clearance, Total
( Clt )

86
Q

The clearance “performed” by the
kidney.

A

Clearance, Renal (Clr)

87
Q

The clearance “performed’ by the
liver.

A

Clearance, Hepatic (Clh)

88
Q

Highest plasma concentration
achieved following a single non-
intravenous dose of a drug.

A

Peak plasma concentration ( Cmax )

89
Q

Plasma concentration , may be
followed by a subscript for time (Cpt –
see Cp0 below)

A

Plasma concentration ( Cp )

90
Q

The plasma concentration at zero
time. Determine by extrapolating the
plasma concentration versus time
“curve” back to the Y (concentration)
axis.

A

Plasma concentration at
time zero
( Cp0 )

91
Q

Portion of a non-intravenous dose of
drug that reaches the systemic
circulation.

A

Fraction of dose absorbed ( F )

92
Q

Time required to eliminate 50% of
any amount of drug from the body.

A

Half-life of elimination ( T1/2 )

93
Q

The time that the Cmax (above) is
achieved following a single non
intravenous dose of drug.

A

Time of the peak
plasma concentration (Tmax)

94
Q

The volume calculated using the
intercept of the “z” portion of a curve
and the Y axis

A

Volume of distribution
( Vz )

95
Q

Unit for Clearance, Total (Clt)

A

1/hr/kg

96
Q

Unit for Clearance, Renal (Clr)

A

1/hr/kg

97
Q

unit for Peak plasma concentration (Cmax),
Plasma concentration ( Cp), and
Cp0

A

mg/ml
(or)
mg/liter

98
Q

Unit for Fraction of dose absorbed (F)

A

None or
%

99
Q

unit for Half-life of elimination (T1/2) and Tmax

A

hrs (or)
minutes

100
Q

unit for Volume of distribution ( Vz)

A

L/kg